Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Sitz-Markers
United Therapeutics Europe Ltd
Return of Bowel Function After Colon Surgery
1 trial -
Sivelestat
The First People's Hospital of Lianyungang
Aortic Dissection
1 trial -
Sivelestat sodium
The First People's Hospital of Lianyungang
Aortic Dissection
1 trial -
Snap
The First People's Hospital of Lianyungang
Arrhythmia
1 trial -
Sodium Bicarbonate Ringer's Solution
The First People's Hospital of Lianyungang
Hyperlactacidemia
1 trial -
Soy protein
United Therapeutics Europe Ltd
Photoaging
1 trial -
Specific Carbohydrate Diet
NORTHWEST BIOTHERAPEUTICS INC
Clostridium Difficile Infection
1 trial -
Sperm test
The First People's Hospital of Lianyungang
Covid19
1 trial -
Split dose of 4L PEG
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Health Behavior
1 trial -
Standard Care Arm
United Therapeutics Europe Ltd
Radiation Proctopathy
1 trial -
Standard clinical treatment
The First People's Hospital of Lianyungang
Acute Pancreatitis
1 trial -
Standard of Care medication for early Alzheimer's Disease
BRIGHT MINDS BIOSCIENCES INC.
Alzheimer Disease
1 trial -
Stapokibart
The First People's Hospital of Lianyungang
Primary Cutaneous Amyloidosis
1 trial -
Stereotactic body radiotherapy (SBRT)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
HSCT
1 trial -
Steroid and Proton Pump Inhibitor Therapy
Takeda
Suspected Eosinophilic Esophagitis
1 trial -
Study subjects will be vaccinated with 3 (three) vaccine doses. The first vaccine will be administered intramuscularly starting at 6-12 weeks of age followed by two doses at four-week interval
Biotech Pharmaceutical Co.,
Diphtheria
1 trial -
Suanzaoren Decoction and Huanglian Wendan Decoction
The First People's Hospital of Lianyungang
Traditional Chinese Medicine
1 trial -
Subconjunctival dexamethasone and general anesthesia
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cataract
1 trial -
Sucrose Iron，subcutaneous recombinant human erythropoietin，intravenous vitamin C
The First People's Hospital of Lianyungang
Anemia
1 trial -
Sufentanil
The First People's Hospital of Lianyungang
Anesthesia
1 trial -
Sulfadoxine-pyrimethamine
United Therapeutics Europe Ltd
Anaemia
1 trial -
Sulfentanyl
The First People's Hospital of Lianyungang
Postoperative Nausea and Vomiting
1 trial -
Super Cereal Plus (SC+)
United Therapeutics Europe Ltd
Moderate Acute Malnutrition (MAM)
1 trial -
Supplementary Food
United Therapeutics Europe Ltd
Moderate Acute Malnutrition
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources